Integrated Genomic and Proteomic Drug Target Discovery for Vascular Dementia and Alzheimer’s Disease (P3-3.015)
To utilize a comprehensive multi-omic approach to identify novel drug targets that mediate the genetic risk of vascular dementia (VaD) and Alzheimer’s disease (AD).
Authors
- Shufan Huo
- Jessica Magid-Bernstein (ORCID: https://orcid.org/0000-0001-6506-6017)
- Lauren Hachmann Sansing (ORCID: https://orcid.org/0000-0002-6898-1680)
- Srikant Rangaraju (ORCID: https://orcid.org/0000-0003-2765-1500)
- Cyprien A. Rivier (ORCID: https://orcid.org/0000-0002-1148-1829)
- Guido J. Falcone (ORCID: https://orcid.org/0000-0002-6407-0302)
- Kevin Navin Sheth (ORCID: https://orcid.org/0000-0003-2003-5473)
- Richa Sharma (ORCID: https://orcid.org/0000-0003-0798-2353)
- Santiago Clocchiatti‐Tuozzo (ORCID: https://orcid.org/0000-0001-5377-434X)
Institutions
- Yale University (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211466
- Primary Topic
- Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00